OC
MDWD icon

Oppenheimer & Co’s MediWound MDWD Stock Holding History

Oppenheimer & Co’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Sell
16,013
-4,179
-21% -$66.3K ﹤0.01% 1588
2026
Q1 		$325K Buy
20,192
+100
+0.5% +$1.74K ﹤0.01% 1357
2025
Q4 		$371K Buy
+20,092
New +$367K 0.01% 1194
2021
Q1 		– Sell
-5,557
Closed -$144K – 1483
2020
Q4 		$144K Buy
5,557
+243
+5% +$6.31K ﹤0.01% 1286
2020
Q3 		$140K Sell
5,314
-572
-10% -$14.6K ﹤0.01% 1206
2020
Q2 		$122K Hold
5,886
– – ﹤0.01% 1189
2020
Q1 		$65K Sell
5,886
-428
-7% -$7.9K ﹤0.01% 1147
2019
Q4 		$137K Sell
6,314
-629
-9% -$13K ﹤0.01% 1223
2019
Q3 		$156K Buy
6,943
+686
+11% +$15.2K ﹤0.01% 1185
2019
Q2 		$148K Buy
6,257
+1,571
+34% +$48.5K ﹤0.01% 1230
2019
Q1 		$164K Buy
4,686
+286
+7% +$9.62K ﹤0.01% 1259
2018
Q4 		$125K Hold
4,400
– – ﹤0.01% 1167
2018
Q3 		$189K Hold
4,400
– – ﹤0.01% 1242
2018
Q2 		$213K Sell
4,400
-286
-6% -$12.3K 0.01% 1201
2018
Q1 		$171K Sell
4,686
-385
-8% -$12.1K ﹤0.01% 1243
2017
Q4 		$158K Buy
5,071
+1,314
+35% +$44.2K ﹤0.01% 1244
2017
Q3 		$141K Buy
3,757
+257
+7% +$11.3K ﹤0.01% 1227
2017
Q2 		$167K Sell
3,500
-171
-5% -$7.96K ﹤0.01% 1215
2017
Q1 		$170K Sell
3,671
-1,286
-26% -$52.6K ﹤0.01% 1195
2016
Q4 		$159K Buy
4,957
+2,814
+131% +$115K ﹤0.01% 1192
2016
Q3 		$116K Buy
+2,143
New +$114K ﹤0.01% 1201
2015
Q4 		– Sell
-4,029
Closed -$215K – 1328
2015
Q3 		$215K Sell
4,029
-5,114
-56% -$251K 0.01% 1136
2015
Q2 		$453K Sell
9,143
-2,043
-18% -$88.9K 0.01% 928
2015
Q1 		$567K Buy
11,186
+3,672
+49% +$196K 0.02% 816
2014
Q4 		$350K Buy
7,514
+2,628
+54% +$108K 0.01% 970
2014
Q3 		$215K Buy
+4,886
New +$281K 0.01% 1215

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oppenheimer & Co's MDWD Position: Q2 2026 in Review

Oppenheimer & Co reduced its MediWound (MDWD) stake by 21% in Q2 2026, selling an estimated $66.3K and leaving 16,013 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

Oppenheimer & Co first reported a position in MDWD in Q3 2014 and has held it in 26 quarters since. The position peaked at $567K in Q1 2015. 78 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • Oppenheimer & Co held 16,013 shares of MediWound worth $235K as of Q2 2026.
  • Oppenheimer & Co sold 4,179 MediWound shares in Q2 2026, an estimated $66.3K.
  • MediWound made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1588 holding.
  • Oppenheimer & Co first reported a position in MediWound in Q3 2014 and has held it in 26 quarters since.
  • Oppenheimer & Co's MediWound position peaked at $567K in Q1 2015.
  • 78 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.